These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19684255)

  • 1. Immunoneutralization of agmatine sensitizes mice to micro-opioid receptor tolerance.
    Wade CL; Eskridge LL; Nguyen HO; Kitto KF; Stone LS; Wilcox G; Fairbanks CA
    J Pharmacol Exp Ther; 2009 Nov; 331(2):539-46. PubMed ID: 19684255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.
    Xie H; Woods JH; Traynor JR; Ko MC
    Anesth Analg; 2008 Jun; 106(6):1873-81. PubMed ID: 18499626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
    Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice.
    Gadotti VM; Tibola D; Paszcuk AF; Rodrigues AL; Calixto JB; Santos AR
    Brain Res; 2006 Jun; 1093(1):116-22. PubMed ID: 16765330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
    Narita M; Mizoguchi H; Kampine JP; Tseng LF
    Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse.
    Roberts JC; Grocholski BM; Kitto KF; Fairbanks CA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1226-33. PubMed ID: 15933157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal pretreatment with antisense oligodeoxynucleotides against exon-1, -4, or -8 of mu-opioid receptor clone leads to differential loss of spinal endomorphin-1-and endomorphin-2-induced antinociception in the mouse.
    Wu HE; Mizoguchi H; Terashvili M; Leitermann RJ; Hung KC; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 2002 Nov; 303(2):867-73. PubMed ID: 12388674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of agmatine on DAMGO-induced mu-opioid receptor down-regulation and internalization via activation of IRAS, a candidate for imidazoline I(1) receptor.
    Gao Y; Li F; Wu N; Su RB; Liu Y; Lu XQ; Liu Y; Li J
    Eur J Pharmacol; 2008 Dec; 599(1-3):18-23. PubMed ID: 18845140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord.
    Madia PA; Navani DM; Yoburn BC
    Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal RGS4 inhibitor, CCG50014, reduces nociceptive responses and enhances opioid-mediated analgesic effects in the mouse formalin test.
    Yoon SY; Woo J; Park JO; Choi EJ; Shin HS; Roh DH; Kim KS
    Anesth Analg; 2015 Mar; 120(3):671-677. PubMed ID: 25695583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids.
    Marker CL; Luján R; Loh HH; Wickman K
    J Neurosci; 2005 Apr; 25(14):3551-9. PubMed ID: 15814785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors.
    Riba P; Ben Y; Smith AP; Furst S; Lee NM
    J Pharmacol Exp Ther; 2002 Jan; 300(1):265-72. PubMed ID: 11752125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of spinal alpha-2 adrenoceptors, but not mu-opioid receptors, reduces the intrathecal N-methyl-D-aspartate-induced increase in spinal NR1 subunit phosphorylation and nociceptive behaviors in the rat.
    Roh DH; Seo HS; Yoon SY; Song S; Han HJ; Beitz AJ; Lee JH
    Anesth Analg; 2010 Feb; 110(2):622-9. PubMed ID: 20007733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal nitric oxide contributes to the analgesic effect of intrathecal [d-pen2,d-pen5]-enkephalin in normal and diabetic rats.
    Chen SR; Pan HL
    Anesthesiology; 2003 Jan; 98(1):217-22. PubMed ID: 12503000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance develops to the antiallodynic effects of the peripherally acting opioid loperamide hydrochloride in nerve-injured rats.
    He SQ; Yang F; Perez FM; Xu Q; Shechter R; Cheong YK; Carteret AF; Dong X; Sweitzer SM; Raja SN; Guan Y
    Pain; 2013 Nov; 154(11):2477-2486. PubMed ID: 23880055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excitatory amino acid receptor subtype agonists induce feeding in the nucleus accumbens shell in rats: opioid antagonist actions and interactions with mu-opioid agonists.
    Echo JA; Lamonte N; Christian G; Znamensky V; Ackerman TF; Bodnar RJ
    Brain Res; 2001 Dec; 921(1-2):86-97. PubMed ID: 11720714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
    Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
    Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.